98 related articles for article (PubMed ID: 8455944)
1. A cell culture model system for genetic analyses of the cell cycle by targeted homologous recombination.
Prouty SM; Hanson KD; Boyle AL; Brown JR; Shichiri M; Follansbee MR; Kang W; Sedivy JM
Oncogene; 1993 Apr; 8(4):899-907. PubMed ID: 8455944
[TBL] [Abstract][Full Text] [Related]
2. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
3. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.
Mateyak MK; Obaya AJ; Adachi S; Sedivy JM
Cell Growth Differ; 1997 Oct; 8(10):1039-48. PubMed ID: 9342182
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cell cycle duration by c-myc levels.
Karn J; Watson JV; Lowe AD; Green SM; Vedeckis W
Oncogene; 1989 Jun; 4(6):773-87. PubMed ID: 2660073
[TBL] [Abstract][Full Text] [Related]
5. Effects of c-raf-1 and c-myc expression on radiation response in an in vitro model of human small-cell-lung carcinoma.
Pfeifer A; Mark G; Leung S; Dougherty M; Spillare E; Kasid U
Biochem Biophys Res Commun; 1998 Nov; 252(2):481-6. PubMed ID: 9826556
[TBL] [Abstract][Full Text] [Related]
6. Regulation of c-myc expression by Ras/Raf signalling.
Kerkhoff E; Houben R; Löffler S; Troppmair J; Lee JE; Rapp UR
Oncogene; 1998 Jan; 16(2):211-6. PubMed ID: 9464539
[TBL] [Abstract][Full Text] [Related]
7. Transformation of hemopoietic cells by raf and myc oncogenes: a new perspective on lineage commitment.
Klinken SP
Cancer Cells; 1991 Oct; 3(10):373-82. PubMed ID: 1777358
[TBL] [Abstract][Full Text] [Related]
8. Proto-oncogene expression in human glomerular diseases.
Takemura T; Okada M; Akano N; Murakami K; Hino S; Yagi K; Takekoshi Y; Yoshioka K
J Pathol; 1996 Mar; 178(3):343-51. PubMed ID: 8778342
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
Nass SJ; Dickson RB
Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
11. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
Chen HW; Huang HC
Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
[TBL] [Abstract][Full Text] [Related]
12. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
Lepique AP; Moraes MS; Rocha KM; Eichler CB; Hajj GN; Schwindt TT; Armelin HA
J Mol Endocrinol; 2004 Dec; 33(3):623-38. PubMed ID: 15591023
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis.
Klock G; Storch S; Rickert J; Gutacker C; Koch-Brandt C
J Cell Physiol; 1998 Dec; 177(4):593-605. PubMed ID: 10092212
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cell cycle entry and G1 progression by CSF-1.
Roussel MF
Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle synchronization of FRTL5 cells. A physiological model system.
Degrassi A; Monaco MC; Lisignoli G; Belvedere O; Toneguzzi S; Malangone W; Bonora ML; Piacentini A; Lavaroni S; Scarbolo M; Ambesi-Impiombato FS; Facchini A
J Exp Clin Cancer Res; 1998 Dec; 17(4):527-32. PubMed ID: 10089079
[TBL] [Abstract][Full Text] [Related]
16. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
[TBL] [Abstract][Full Text] [Related]
17. [Construction of antisense c-myc recombinant adenovirus and its anti-tumor effects on osteosarcoma cell lines MG-63 and U2OS].
Xie XK; Yang DS; Ye ZM; Tao HM
Ai Zheng; 2005 Mar; 24(3):292-7. PubMed ID: 15757529
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation.
Cioffi CL; Garay M; Johnston JF; McGraw K; Boggs RT; Hreniuk D; Monia BP
Mol Pharmacol; 1997 Mar; 51(3):383-9. PubMed ID: 9058592
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells.
Feng R; Shen S; Hui H; Jin M
Chin Med J (Engl); 1997 Nov; 110(11):847-50. PubMed ID: 9772416
[TBL] [Abstract][Full Text] [Related]
20. Proto-oncogene mRNA levels and activities of multiple transcription factors in C3H 10T 1/2 murine embryonic fibroblasts exposed to 835.62 and 847.74 MHz cellular phone communication frequency radiation.
Goswami PC; Albee LD; Parsian AJ; Baty JD; Moros EG; Pickard WF; Roti Roti JL; Hunt CR
Radiat Res; 1999 Mar; 151(3):300-9. PubMed ID: 10073668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
